Parth PatelMD
MD · Perelman School of Medicine at the University of Pennsylvania
Residency · Brigham and Women's Hospital
Fellowship · Cardiovascular Disease Fellowshipalumni
publications
33
first author
8
median RCR
1.14
citations
740
Publications
- 2024SECRETS REVEALED: A CASE OF PRIMARY MITRAL VALVE PROLAPSE IN HYPERTROPHIC CARDIOMYOPATHYJournal of the American College of Cardiology
- 2023Contribution of Previously Unrecognized RNA Splice-Altering Variants to Congenital Heart DiseaseCirculation: Genomic and Precision MedicineRCR 1.1412 citesPMID 37165897
- 2021Virtual optimization of guideline‐directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT‐HF pilot studyEuropean Journal of Heart FailureRCR 3.9069 citesPMID 33768599
- 2021Contribution of Noncanonical Splice Variants to TTN Truncating Variant CardiomyopathyCirculation: Genomic and Precision Medicinefirst authorRCR 1.1522 citesPMID 34461741
- 2021Genetic Background and Kinetics Define Wound Bed Extracellular Vesicles in a Mouse Model of Cutaneous InjuryInternational Journal of Molecular SciencesRCR 0.497 citesPMID 33805585
- 2020Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic DiseaseCirculationRCR 2.8146 citesPMID 33185476
- 2020Serum extracellular vesicle miR-203a-3p content is associated with skeletal muscle mass and protein turnover during disuse atrophy and regrowthAmerican Journal of Physiology-Cell PhysiologyRCR 1.4123 citesPMID 32639875
- 2020Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular diseaseGlobal Cardiology Science and Practicefirst authorRCR 0.9717 citesPMID 33598499
- 2020SEQUENCE VARIANTS IN TITIN CAUSING SPLICING DEFECTS AND CARDIOMYOPATHY: INSIGHTS FOR GENE BASED DIAGNOSIS AND NORMAL PHYSIOLOGYJournal of the American College of Cardiologyfirst author
- 2020
- 2019Genetic Variants Associated With Cancer Therapy–Induced CardiomyopathyCirculationRCR 10.81264 citesPMID 30987448
- 2019Cardiovascular risk reduction with icosapent ethylCurrent Opinion in Cardiologyfirst authorRCR 0.7220 citesPMID 31464773
- 2018In Vivo and In Vitro Methods to Identify DNA Sequence Variants that Alter RNA SplicingCurrent Protocols in Human Geneticsfirst authorRCR 0.236 citesPMID 30038698
- 2018Genetic Predisposing Variants Associated with Cancer Therapy-Induced CardiomyopathySSRN Electronic Journal
- 2017Identification of pathogenic gene mutations in <i>LMNA</i> and <i>MYBPC3</i> that alter RNA splicingProceedings of the National Academy of SciencesRCR 2.4580 citesPMID 28679633
- 2017Lynch Syndrome and Muir-Torre Syndrome: An update and review on the genetics, epidemiology, and management of two related disordersDermatology Online JournalRCR 1.2027 citesPMID 29447627
- 2017A current perspective on the oncopreventive and oncolytic properties of selective serotonin reuptake inhibitorsBiomedicine & Pharmacotherapysenior authorRCR 0.9123 citesPMID 28088112
- 2016Human retinal progenitor sheet transplants in immunodeficient retinal degenerate (RD) ratsInvestigative Ophthalmology & Visual Science
- 2015Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cellsBiomedicine & PharmacotherapyRCR 0.9325 citesPMID 26796280
- 2014Human Experimental Endotoxemia in Modeling the Pathophysiology, Genomics, and Therapeutics of Innate Immunity in Complex Cardiometabolic DiseasesArteriosclerosis Thrombosis and Vascular Biologyfirst authorRCR 1.5446 citesPMID 25550206
- 2014A Functional Synonymous Coding Variant in the <i>IL1RN</i> Gene Is Associated with Survival in Septic ShockAmerican Journal of Respiratory and Critical Care MedicineRCR 1.1341 citesPMID 25089931
- 2012Peroxisome Proliferator–Activated Receptor‐α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked EndotoxemiaJournal of the American Heart AssociationRCR 0.3512 citesPMID 23130172
- 2012546Critical Care Medicine
- 2012Abstract 482: Peroxisome Proliferator-Activated Receptor α Modulation with Fenofibrate Does Not Alter the Clinical or Inflammatory Responses to Evoked Endotoxemia in HumansArteriosclerosis Thrombosis and Vascular Biology
Compiled from public program rosters and open scholarly data (PubMed, OpenAlex, ORCID) with field-normalized impact (NIH iCite RCR). Publication attribution is being actively improved; counts shown are conservative.